Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER) Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2018
NCT03914131
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)